Evidence map›Paper›PMID 25097261›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.

Sonia Salzano, Paola Checconi, Eva-Maria Hanschmann, Christopher Horst Lillig, Lucas D Bowler, Philippe Chan, David Vaudry, Manuela Mengozzi, Lucia Coppo, Sandra Sacre and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 2 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 2 syntheses or guidelines pooled it, 364 citations in OpenAlex.

  1. Coenzyme QNutrients · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Journal of xenobiotics · 2025
    Article
  18. Article
  19. Article
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Sonia SalzanoBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom;
Paola ChecconiBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom;Department of Public Health and Infectious Diseases, Institut Pasteur, Cenci-Bolognetti Foundation, Sapienza University of Rome, 00185 Rome, Italy;
Eva-Maria HanschmannInstitute for Medical Biochemistry and Molecular Biology, University Medicine, Ernst-Moritz-Arndt University, 17475 Greifswald, Germany;
Christopher Horst LilligInstitute for Medical Biochemistry and Molecular Biology, University Medicine, Ernst-Moritz-Arndt University, 17475 Greifswald, Germany;
Lucas D BowlerSchool of Life Sciences, University of Sussex, Falmer BN19RY, United Kingdom;
Philippe ChanInstitute for Research and Innovation in Biomedicine, Rouen University, 76821 Rouen, France;Platform in Proteomics PISSARO, 76821 Mont-Saint-Aignan, France; and.
David VaudryInstitute for Research and Innovation in Biomedicine, Rouen University, 76821 Rouen, France;Platform in Proteomics PISSARO, 76821 Mont-Saint-Aignan, France; and.
Manuela MengozziBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom;
Lucia CoppoBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom;
Sandra SacreBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom;
Kondala R AtkuriDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305.
Bita SahafDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305.
Leonard A HerzenbergDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305.
Leonore A HerzenbergDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305.
Lisa MullenBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom;
Pietro GhezziBrighton and Sussex Medical School, Falmer BN19RY, United Kingdom; p.ghezzi@bsms.ac.uk.
Brighton and Sussex Medical School · GBStanford University · USUniversität Greifswald · DEUniversité de Rouen Normandie · FRUniversity of Sussex · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism by which oxidative stress induces inflammation and vice versa is unclear but is of great importance, being apparently linked to many chronic inflammatory diseases. We show here that inflammatory stimuli induce release of oxidized peroxiredoxin-2 (PRDX2), a ubiquitous redox-active intracellular enzyme. Once released, the extracellular PRDX2 acts as a redox-dependent inflammatory mediator, triggering macrophages to produce and release TNF-α. The oxidative coupling of glutathione (GSH) to PRDX2 cysteine residues (i.e., protein glutathionylation) occurs before or during PRDX2 release, a process central to the regulation of immunity. We identified PRDX2 among the glutathionylated proteins released in vitro by LPS-stimulated macrophages using mass spectrometry proteomic methods. Consistent with being part of an inflammatory cascade, we find that PRDX2 then induces TNF-α release. Unlike classical inflammatory cytokines, PRDX2 release does not reflect LPS-mediated induction of mRNA or protein synthesis; instead, PRDX2 is constitutively present in macrophages, mainly in the reduced form, and is released in the oxidized form on LPS stimulation. Release of PRDX2 is also observed in human embryonic kidney cells treated with TNF-α. Importantly, the PRDX2 substrate thioredoxin (TRX) is also released along with PRDX2, enabling an oxidative cascade that can alter the -SH status of surface proteins and thereby facilitate activation via cytokine and Toll-like receptors. Thus, our findings suggest a model in which the release of PRDX2 and TRX from macrophages can modify the redox status of cell surface receptors and enable induction of inflammatory responses. This pathway warrants further exploration as a potential novel therapeutic target for chronic inflammatory diseases.

Indexed as

Oxidative StressAnimalsBlotting, WesternCell LineGlutathioneHumansInflammationLipopolysaccharidesMacrophagesMicePeroxiredoxinsGlutathioneLipopolysaccharidesPeroxiredoxinscysteine oxidationredox proteomicsthiol oxidation

Identifiers

PMID25097261
PMCPMC4143057
OpenAlexW2039854830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.